DJIA 16,071.63 57.25 0.36%
NASDAQ 4,322.13 53.36 1.25%
S&P 500 1,867.95 15.74 0.85%
market minute promo

6.17 0.21 (3.52%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACHN $6.17 3.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.02
Previous Close $5.96
Daily Range $5.91 - $6.27
52-Week Range $5.67 - $12.94
Market Cap $842.5M
P/E Ratio -15.28
Dividend (Yield) $0.00 (0.0%)
Volume 254,167
Average Daily Volume 1,966,737
Current FY EPS -$0.12

Sector

Healthcare

Industry

Drug Makers

ACHILLION PHARMACEUTICALS, INC. (ACHN) Description

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website: http://www.achillion.com/

News & Commentary

Why Achillion Pharmaceuticals Shares Crashed 37% in January

Investors continue to sell off the once-promising developer of hepatitis C drugs.

Zacks.com featured expert Kevin Matras highlights: Achillion Pharmaceuticals, Opko Health, Global Ea

Zacks.com featured expert Kevin Matras highlights: Achillion Pharmaceuticals, Opko Health, Global Eagle Entertainment, LendingClub and Barracuda Networks

A Company's First Profit Can Mean Big Profits to Investors

Achillion Pharmaceuticals (ACHN) Weak On High Volume

First Week of ACHN September 16th Options Trading

The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceu

The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceuticals and Inovio Pharmaceuticals

Achillion Pharmaceuticals is Now Oversold (ACHN)

Commit To Purchase Achillion Pharmaceuticals At $5, Earn 12% Using Options

Bristol-Myers (BMY) Collaborates with Dual Therapeutics

Achillion Pharmaceuticals (ACHN) Flagged As Strong On High Volume

See More ACHN News...

ACHN's Top Competitors

ACHN $6.17 (3.52%)
Current stock: ACHN
AMGN $144.89 (1.21%)
Current stock: AMGN
GILD $89.00 (2.01%)
Current stock: GILD
BIIB $251.85 (0.74%)
Current stock: BIIB